2006
DOI: 10.1002/cyto.b.20112
|View full text |Cite
|
Sign up to set email alerts
|

Routine immunophenotyping in acute leukemia: Role in lineage assignment and reassignment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
10
0

Year Published

2006
2006
2019
2019

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 14 publications
(10 citation statements)
references
References 12 publications
0
10
0
Order By: Relevance
“…Qadir et al. reported a retrospective analysis of 612 patients with de novo acute leukemia (30). Of the 525 cases with AML based on morphology and cytochemistry, three cases had lymphoid immunophenotypes.…”
Section: Discussionmentioning
confidence: 99%
“…Qadir et al. reported a retrospective analysis of 612 patients with de novo acute leukemia (30). Of the 525 cases with AML based on morphology and cytochemistry, three cases had lymphoid immunophenotypes.…”
Section: Discussionmentioning
confidence: 99%
“…Immunophenotyping is an important diagnostic tool for decision making in various diseases [1][2][3][4][5][6]. Typical examples are: -diagnosis of immunodeficiencies [7], -monitoring of systemic and chronic diseases [8][9][10][11][12], -cellular diagnostics of allergy [13,14], -functional characterization of cells [15,16], -genetic investigation [17,18], -differential diagnosis of lymphocytosis [19], -diagnosis of leukemia [5,[20][21][22][23][24], -investigation of T-cell receptor expression in Kawasaki syndrome [25][26], -investigation of pregnancy disturbances [27], -quality control in hemotherapy [28][29][30]. Furthermore, there are several indications that are presently not so important for routine diagnostics [31].…”
Section: Introductionmentioning
confidence: 99%
“…In the present study 56 cases, were evaluated, by studying their morphology using cytochemical stains, as well as clinical features, and with 6 cases for concordant Immunophenotyping, using lineage specific panels with markers. 1,12,13,14,15 Of the 56 cases, 36 cases were acute leukaemias (64%), of which 24 were AML (43%), and 12 were ALL (22%). The rest 20 cases were chronic cases (36%), of which 17 were CML (30%), which include one case of chronic neutrophilic leukaemia, and 3 were CLL cases (5%).…”
Section: Discussionmentioning
confidence: 99%